Experimental findings showed intrathecal synthesis of MMP-9 in MS and its increased levels in the cerebrospinal fluid and serum of relapsing-remitting MS patients compared with primary progressive and healthy control subjects [65,66,67]. This evidence concerns the gene MMP9 and relapsing-remitting multiple sclerosis.